142 related articles for article (PubMed ID: 30905216)
1. Transdermal metformin hydrochloride-loaded cubic phases: in silico formulation optimization, preparation, properties, and application for local treatment of melanoma.
Yu X; Zhou W; Wang H; Lu S; Jin Y; Fu J
Drug Deliv; 2019 Dec; 26(1):376-383. PubMed ID: 30905216
[TBL] [Abstract][Full Text] [Related]
2. Transdermal Cubic Phases of Metformin Hydrochloride: In Silico and in Vitro Studies of Delivery Mechanisms.
Yu X; Jin Y; Du L; Sun M; Wang J; Li Q; Zhang X; Gao Z; Ding P
Mol Pharm; 2018 Aug; 15(8):3121-3132. PubMed ID: 29979604
[TBL] [Abstract][Full Text] [Related]
3. Melanoma therapy with transdermal mitoxantrone cubic phases.
Yu X; Du L; Zhu L; Liu X; Zhang B; Fu G; Jin Y
Drug Deliv; 2016 Jun; 23(5):1565-70. PubMed ID: 25835224
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo anti-melanoma action of metformin.
Janjetovic K; Harhaji-Trajkovic L; Misirkic-Marjanovic M; Vucicevic L; Stevanovic D; Zogovic N; Sumarac-Dumanovic M; Micic D; Trajkovic V
Eur J Pharmacol; 2011 Oct; 668(3):373-82. PubMed ID: 21806981
[TBL] [Abstract][Full Text] [Related]
5. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
Ahmed KS; Shan X; Mao J; Qiu L; Chen J
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral and transdermal administration of rasagiline mesylate on human melanoma tumor growth in vivo.
Meier-Davis SR; Dines K; Arjmand FM; Hamlin R; Huang B; Wen J; Christianson C; Shudo J; Nagata T
Cutan Ocul Toxicol; 2012 Dec; 31(4):312-7. PubMed ID: 22515841
[TBL] [Abstract][Full Text] [Related]
7. Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel.
Yu X; Du L; Li Y; Fu G; Jin Y
Biomed Pharmacother; 2015 Jul; 73():6-11. PubMed ID: 26211575
[TBL] [Abstract][Full Text] [Related]
8. Dextran methacrylate hydrogel microneedles loaded with doxorubicin and trametinib for continuous transdermal administration of melanoma.
Huang S; Liu H; Huang S; Fu T; Xue W; Guo R
Carbohydr Polym; 2020 Oct; 246():116650. PubMed ID: 32747282
[TBL] [Abstract][Full Text] [Related]
9. Development of an Injectable Slow-Release Metformin Formulation and Evaluation of Its Potential Antitumor Effects.
Baldassari S; Solari A; Zuccari G; Drava G; Pastorino S; Fucile C; Marini V; Daga A; Pattarozzi A; Ratto A; Ferrari A; Mattioli F; Barbieri F; Caviglioli G; Florio T
Sci Rep; 2018 Mar; 8(1):3929. PubMed ID: 29500390
[TBL] [Abstract][Full Text] [Related]
10. Metformin-loaded ethosomes with promoted anti-proliferative activity in melanoma cell line B16, and wound healing aptitude: Development, characterization and in vivo evaluation.
Magdy S; Alaaeldin E; Fathalla Z; Alaaeldin R; Elrehany M; Saber EA; Abdel-Aziz RT; Mansour HF
Int J Pharm; 2022 Jun; 621():121781. PubMed ID: 35489604
[TBL] [Abstract][Full Text] [Related]
11. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
[TBL] [Abstract][Full Text] [Related]
12. Metformin: oxidative and proliferative parameters in-vitro and in-vivo models of murine melanoma.
de Souza Neto FP; Bernardes SS; Marinello PC; Melo GP; Luiz RC; Cecchini R; Cecchini AL
Melanoma Res; 2017 Dec; 27(6):536-544. PubMed ID: 28877050
[TBL] [Abstract][Full Text] [Related]
13. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
[TBL] [Abstract][Full Text] [Related]
14. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
Mundra V; Peng Y; Kumar V; Li W; Miller DD; Mahato RI
Drug Deliv Transl Res; 2015 Jun; 5(3):199-208. PubMed ID: 25924699
[TBL] [Abstract][Full Text] [Related]
15. Transdermal Delivery of Metformin Utilizing Ionic Liquid Technology: Insight Into the Relationship Between Counterion Structures and Properties.
Hong M; Wang Q; Wang K; Li J; Qi MH; Ren GB
Pharm Res; 2022 Oct; 39(10):2459-2474. PubMed ID: 36171345
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of metformin surface modified cellulose nanofiber gel and evaluation of its anti-metastatic potentials.
Nurani M; Akbari V; Taheri A
Carbohydr Polym; 2017 Jun; 165():322-333. PubMed ID: 28363556
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of the in situ hydrogels of curcumin and its inclusion complexes of hydroxypropyl-β-cyclodextrin for melanoma treatment.
Sun Y; Du L; Liu Y; Li X; Li M; Jin Y; Qian X
Int J Pharm; 2014 Jul; 469(1):31-9. PubMed ID: 24746691
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of guttiferone E in melanoma-bearing mice.
Ribeiro AB; de Melo MRS; de Melo Junqueira M; Rodrigues MGL; de Souza TO; Fernandes G; Santos MFC; Ambrósio SR; Bastos JK; Tavares DC
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5265-5274. PubMed ID: 38270618
[TBL] [Abstract][Full Text] [Related]
19. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
20. Framework nucleic acids as programmable carrier for transdermal drug delivery.
Wiraja C; Zhu Y; Lio DCS; Yeo DC; Xie M; Fang W; Li Q; Zheng M; Van Steensel M; Wang L; Fan C; Xu C
Nat Commun; 2019 Mar; 10(1):1147. PubMed ID: 30850596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
